InstantWhyThe numbers
Investing.com reports that Citizens has lowered its stock price target for Sportradar following reduced guidance from the sports data and betting analytics company. The firm has not disclosed the new target level or the size of the reduction. Sportradar has not commented on the guidance revision.
Why it matters
Sports data providers like Sportradar sell feeds and analytics to sportsbooks and media companies, so weaker guidance suggests either fewer new customer wins or existing clients spending less. The timing matters because the U.S. sports betting market has matured rapidly, and operators are shifting from land-grab mode to profitability, which typically means smaller vendor contracts.
How this compares
Wall Street firms have been active in adjusting price targets across technology and consumer sectors in recent weeks. In late July, Goldman Sachs cut its Meta target on infrastructure spending concerns, while BofA lowered forecasts for both Skyworks Solutions over merger execution risk and Trip.com following antitrust penalties in China. Sportradar went public in 2021 and provides live odds, statistics and streaming to betting companies worldwide, with revenue tied to betting handle and the number of events covered.
What to watch
Investors will look for detail on which business lines are underperforming when Sportradar next reports earnings. The company has not confirmed whether the guidance cut stems from customer churn, pricing pressure, or slower expansion in newer markets. Other analysts may follow Citizens in revising their targets if the guidance change reflects broader weakness in sports betting technology spending.
- ✓Detected and written at 2026-08-04 09:56
- ✓First reported by Investing.com
- ✓Written from public facts in our own words — never a copy
- ✓Published as fast as possible; our team holds editorial responsibility
Sources
- Investing.com — News: https://www.investing.com/news/analyst-ratings/citizens-cuts-sportradar-stock-price-target-on-lowered-guidance-93CH-4833331
More stories
InstantWhyProcter & Gamble to acquire supplements brand Thorne in health business expansion
InstantWhyTwo charged in federal drug trafficking probe in southern Maryland
InstantWhy